Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018;54(0):100-118.
doi: 10.1540/jsmr.54.100.

The impact of Pompe disease on smooth muscle: a review

Affiliations
Review

The impact of Pompe disease on smooth muscle: a review

Angela L McCall et al. J Smooth Muscle Res. 2018.

Abstract

Pompe disease (OMIM 232300) is an autosomal recessive disorder caused by mutations in the gene encoding acid α-glucosidase (GAA) (EC 3.2.1.20), the enzyme responsible for hydrolyzing lysosomal glycogen. The primary cellular pathology is lysosomal glycogen accumulation in cardiac muscle, skeletal muscle, and motor neurons, which ultimately results in cardiorespiratory failure. However, the severity of pathology and its impact on clinical outcomes are poorly described in smooth muscle. The advent of enzyme replacement therapy (ERT) in 2006 has improved clinical outcomes in infantile-onset Pompe disease patients. Although ERT increases patient life expectancy and ventilator free survival, it is not entirely curative. Persistent motor neuron pathology and weakness of respiratory muscles, including airway smooth muscles, contribute to the need for mechanical ventilation by some patients on ERT. Some patients on ERT continue to experience life-threatening pathology to vascular smooth muscle, such as aneurysms or dissections within the aorta and cerebral arteries. Better characterization of the disease impact on smooth muscle will inform treatment development and help anticipate later complications. This review summarizes the published knowledge of smooth muscle pathology associated with Pompe disease in animal models and in patients.

Keywords: Pompe disease; airway; gastrointestinal; smooth muscle; vasculature.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Glycogen Deposits found within Airway Smooth Muscle of Gaa−/− Mouse. Representative images of fixed and plastic embedded tissue, sectioned, and stained with Periodic Acid-Schiff reagents to detect glycogen, then counterstained with Toluidine Blue. 2μm sections from the trachealis of six-month-old (A) wildtype and (B) Gaa−/− mice are indicative of the smooth muscle found along the airway musculature. Aggregates of pink puncta indicate large deposits of glycogen within lysosomes. Scale bar = 20 μm.
Fig. 2.
Fig. 2.
Glycogen Deposits found within Vascular, GI, and GU Smooth Muscle of Gaa−/− Mouse. Representative images of fixed and plastic embedded tissue, sectioned to, and stained with Periodic Acid-Schiff reagents to detect glycogen, then counterstained with Toluidine Blue. 2μm sections from the esophagus of six-month-old (A and C) wildtype and (B and D) Gaa−/− mice are indicative of the smooth muscle found along the vascular system (A and B) as well as within the gastrointestinal tract (C and D). 2μm sections from the bladder of (E) wildtype and (F) Gaa−/− mice represent the pathology present in the genitourinary. Aggregates of pink puncta indicate large deposits of glycogen within lysosomes. Scale bar = 20 μm.

References

    1. Hers HG. alpha-Glucosidase deficiency in generalized glycogenstorage disease (Pompe’s disease). Biochem J. 1963; 86: 11–6. doi: 10.1042/bj0860011 - DOI - PMC - PubMed
    1. van den Hout HMP, Hop W, van Diggelen OP, Smeitink JAM, Smit GPA, Poll-The BTT, Bakker HD, Loonen MCB, de Klerk JBC, Reuser AJJ, van der Ploeg AT. The natural course of infantile Pompe’s disease: 20 original cases compared with 133 cases from the literature. Pediatrics. 2003; 112(2): 332–40. doi: 10.1542/peds.112.2.332 - DOI - PubMed
    1. Kishnani PS, Hwu WL, Mandel H, Nicolino M, Yong F, Corzo D, Infantile-Onset Pompe Disease Natural History Study Group. A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease. J Pediatr. 2006; 148(5): 671–6. doi: 10.1016/j.jpeds.2005.11.033 - DOI - PubMed
    1. Kishnani PS, Steiner RD, Bali D, Berger K, Byrne BJ, Case LE, Crowley JF, Downs S, Howell RR, Kravitz RM, Mackey J, Marsden D, Martins AM, Millington DS, Nicolino M, O’Grady G, Patterson MC, Rapoport DM, Slonim A, Spencer CT, Tifft CJ, Watson MS. Pompe disease diagnosis and management guideline. Genet Med. 2006; 8(5): 267–88. doi: 10.1097/01.gim.0000218152.87434.f3 - DOI - PMC - PubMed
    1. Beratis NG, LaBadie GU, Hirschhorn K. Genetic heterogeneity in acid alpha-glucosidase deficiency. Am J Hum Genet. 1983; 35(1): 21–33. - PMC - PubMed

Publication types